BEST4⁺ cells are defined by a distinctive combination of genes, including BEST4, OTOP2, CA7 and GUCY2C. In the small intestine, they also show particularly high expression of CFTR, the chloride and bicarbonate channel best known for its role in cystic fibrosis. Together, these markers suggest a specialized role in moving negatively charged ions across the epithelium. Chloride and bicarbonate transport draw water into or out of the intestinal lumen and help regulate the chemical environment surrounding epithelial cells and mucus. OTOP2 adds a sensing capability: this proton-selective channel can respond to changes in extracellular acidity. CA7 may support intracellular bicarbonate production, while GUCY2C encodes guanylyl cyclase C, a receptor that converts extracellular signals into cyclic GMP. The resulting molecular profile is unusually coherent for a relatively small cell population.

The cells were first associated with the intestinal epithelium through studies of bestrophin expression, but modern single-cell sequencing made their identity much clearer. These analyses separate individual epithelial cells according to their RNA profiles, allowing researchers to identify populations that conventional staining can overlook. BEST4⁺ cells appear early in human intestinal development, reportedly as early as gestational week 11, and generally represent less than 5 percent of the fetal epithelial compartment. In adults, their abundance varies by region, with reported enrichment in parts of the jejunum, ileum and colon. Small-intestinal cells are concentrated toward the upper and middle villus, whereas colonic cells tend to occupy apical crypt regions. The regional differences suggest that a shared core program may be adapted to local pH, microbial exposure, mucus and transport demands.

The developmental identity of BEST4⁺ cells is still being debated. Several lines of evidence place them near the end of an absorptive differentiation pathway. They occupy post-mitotic compartments, lack conventional proliferation markers and express genes associated with mature enterocytes and colonocytes, including VIL1, AQP8 and SLC26A3. Human organoid experiments indicate that NOTCH signaling is required for their emergence, and the transcription factor SPIB appears indispensable: removing SPIB with CRISPR-based gene editing prevented BEST4⁺ cell generation even when NOTCH signaling remained active. Yet other findings point toward connections with the secretory lineage. Trajectory analyses in human tissue have identified a low-probability link to ATOH1-positive secretory progenitors, while zebrafish lineage-tracing experiments suggest that related cells can arise from secretory precursors. These differences may reflect species, anatomical region or inflammatory state rather than a single universal developmental route.

Under normal conditions, BEST4⁺ cells may act as coordinated pH and ion-transport units. BEST4 belongs to the bestrophin family of calcium-activated anion channels, which can conduct chloride and bicarbonate when intracellular calcium rises. CFTR provides another major route for apical anion secretion. The cells also express guanylin and uroguanylin, the endogenous ligands for GUCY2C, alongside the receptor itself. This arrangement could create an autocrine circuit in which locally produced ligands stimulate cyclic GMP, activate downstream protein kinases and increase CFTR activity. Bicarbonate secretion is important beyond fluid balance: it helps neutralize acidity near the epithelial surface and allows newly released MUC2 mucin to hydrate and expand into an effective protective layer. The review therefore proposes that BEST4⁺ cells may support mucus-barrier assembly in cooperation with goblet cells, although direct proof that these cells provide the critical bicarbonate flux is still lacking.

The same machinery can be exploited during secretory diarrhea. Bacterial heat-stable enterotoxin, or STa, binds and activates GUCY2C, raising intracellular cyclic GMP and stimulating CFTR through protein kinase G. Cholera toxin and the heat-labile toxin of enterotoxigenic Escherichia coli activate adenylate cyclase through persistent cyclic AMP signaling, leading to protein kinase A-mediated CFTR activation. In both cases, excessive chloride and bicarbonate secretion promotes water movement into the lumen. The review highlights evidence that BEST4⁺ cells are unusually equipped for this response because they co-express GUCY2C and CFTR at functionally relevant levels. Human intestinal organoids exposed to these pathways swell as fluid accumulates. Investigational inhibitors of GUCY2C or CFTR can reduce secretion in experimental systems, but broad suppression carries risks because basal GUCY2C signaling also contributes to barrier integrity, mucus hydration and epithelial maintenance.

Viral diarrhea may involve BEST4⁺ cells more indirectly. Porcine epidemic diarrhea virus preferentially damages villus absorptive enterocytes and can impair NHE3, a sodium-hydrogen exchanger needed for sodium-coupled water absorption. Studies in infected piglets have reported reduced expression of several water and nutrient transporters, together with increased ileal CFTR transcripts. Electrical measurements of infected jejunal tissue also indicate enhanced secretory responses. These observations are consistent with a shift away from absorption and toward secretion, and the presence of CFTR-rich BEST4⁺ cells makes them plausible contributors. But the available evidence does not show that the virus infects BEST4⁺ cells or that the cells are responsible for the altered current. Rotavirus offers another possible route: its NSP4 protein disturbs calcium signaling and triggers ADP-dependent calcium waves in neighboring uninfected cells. BEST4⁺ cells could respond as bystander effectors through calcium-sensitive anion channels, but this remains a testable hypothesis.

Norovirus likewise causes changes that could intersect with the BEST4⁺ program, including reduced epithelial resistance and increased electrogenic chloride secretion. The virus can replicate in differentiated enterocytes and some enteroendocrine cells, but there is no direct evidence that mature BEST4⁺ cells support norovirus replication. Inflammation may nevertheless alter their numbers or activity. In human organoids, interferon-gamma increases BEST4⁺ cell differentiation through a SPIB-dependent mechanism, and the resulting cells show stronger CFTR-dependent secretion after toxin exposure. If antiviral inflammation produces a similar response in living intestine, it could amplify fluid loss during acute disease. Conversely, bicarbonate secretion and mucus hydration might aid barrier repair during recovery. The review also connects BEST4⁺ cells to inflammatory bowel disease, where their abundance and expression of transport and metal-buffering genes appear altered, and to cystic fibrosis, in which defective CFTR trafficking may leave these high-CFTR cells unable to regulate anion transport, luminal acidity and mucus hydration.

These possibilities make BEST4⁺ cells attractive but challenging therapeutic targets. A drug that blocks pathological GUCY2C or CFTR activation could reduce fluid loss, yet permanent or systemic inhibition might undermine normal mucosal defense. Experimental CFTR inhibitors have reduced toxin-induced secretion in rodents, although some show limited solubility, rapid washout, narrow dosing windows or off-target effects on mitochondria. A more selective strategy may involve ADRA2A, an adrenergic receptor enriched in human BEST4⁺ cells; activating it suppresses cyclic AMP secretion and reverses cholera-toxin-induced swelling in enriched organoids. Such findings remain preclinical. The next steps will require lineage-specific genetic tools, direct electrophysiological measurements and disease experiments in animals that actually possess a conserved BEST4⁺ population. Conventional laboratory mice lack a canonical intestinal Best4 lineage, making rats, pigs, zebrafish and human organoids complementary rather than interchangeable models. Until researchers can manipulate these cells in vivo, BEST4⁺ cells should be viewed not as a confirmed master switch for viral diarrhea, but as a promising framework for understanding how infection, inflammation and epithelial ion transport converge.

At the molecular level, the proposed hub function depends on the way several transport systems are colocated rather than on BEST4 alone. Bestrophin channels are described as pentameric calcium-sensitive anion channels with a calcium-binding region, a hydrophobic gate and a cytoplasmic regulatory segment. This architecture provides a potential link between intracellular calcium signals and rapid changes in chloride or bicarbonate permeability. In a BEST4⁺ cell, such calcium-dependent conductance could complement CFTR, whose activity is controlled primarily through cyclic-nucleotide signaling. The two routes therefore offer distinct but potentially convergent means of regulating apical anion movement, while OTOP2 and CA7 could help couple that transport activity to the chemical conditions at the epithelial surface.

That arrangement also helps explain why anatomical location matters. BEST4⁺ cells are reported in the proximal small intestine and at the colonic surface, but their associated transport programs are not identical in every region or species. Villus-associated small-intestinal cells encounter different nutrient, acid and fluid gradients from cells near colonic crypt openings. Cross-species conservation supports a shared cellular program, yet conservation of marker genes does not establish conservation of net ion flux. Differences in epithelial architecture, microbiota, mucus organization and channel abundance could alter the physiological contribution of the same transcriptional cell type. Functional comparisons will therefore need to measure transport in defined regions rather than treating all BEST4⁺ cells as equivalent.

A central experimental challenge is separating correlation from cell-specific causation. High BEST4, GUCY2C or CFTR expression identifies a candidate effector population, but whole-organoid swelling, tissue short-circuit current and bulk transporter measurements integrate responses from many epithelial cells. Stronger tests would combine selective deletion or activation of BEST4⁺ cells with live measurements of intracellular pH, calcium, cyclic GMP, bicarbonate flux and mucus expansion. These experiments could determine whether BEST4 itself is the principal anion pathway, whether it mainly amplifies CFTR-mediated secretion, or whether its greatest contribution is sensing and coordinating responses among neighboring cells. They could also clarify whether toxin-induced secretion requires the endogenous guanylin–uroguanylin circuit or is driven predominantly by pharmacological stimulation of GUCY2C.

Therapeutic development will depend on preserving the distinction between pathological hypersecretion and protective basal transport. GUCY2C signaling and bicarbonate movement may contribute to epithelial maintenance and mucus function even while excessive cyclic GMP or cyclic AMP drives diarrhea. This argues for approaches that limit abnormal signal amplitude, duration or cellular targeting instead of eliminating the pathway entirely. Cell-type-resolved physiology, supported by species with a conserved BEST4⁺ population, should help identify that therapeutic window and establish whether the proposed hub is a druggable controller or primarily a useful map of interacting intestinal transport mechanisms.

Subject of Research: BEST4⁺ intestinal epithelial cells and their role in ion transport and diarrheal mechanisms

Article Title: BEST4⁺ cells: a potential hub of intestinal ion transport and diarrhea manipulation

Article References: Qu, H.-Z., & Wang, X.-Q. (2026). BEST4⁺ cells: a potential hub of intestinal ion transport and diarrhea manipulation. Advanced Biotechnology, 4(3), Article 33. https://doi.org/10.1007/s44307-026-00126-7

Image Credits: AI Generated

DOI: 10.1007/s44307-026-00126-7

Keywords: BEST4⁺ cells, intestinal epithelium, ion transport, CFTR, GC-C signaling, secretory diarrhea, viral gastroenteritis, mucus barrier, BEST4, cells, potential, intestinal

The cGAS pathway is normally activated when DNA appears in the wrong cellular compartment. In healthy cells, most DNA is confined to the nucleus and mitochondria. DNA fragments released during infection, cellular stress or tissue damage can instead accumulate in the cytoplasm, where cGAS binds them and produces the signalling molecule cyclic GMP–AMP. This molecule activates the adaptor protein STING, which then triggers a cascade of kinases and transcription factors, including IRF3 and NF-κB. The result is production of type I interferons and other inflammatory mediators. That response is valuable against certain pathogens, but excessive or chronically activated signalling can disrupt tissue function. The new work suggests that in the intestine, this defensive circuitry has consequences far beyond local immunity, influencing the metabolic conversation between the gut microbiota and adipose tissue.

The researchers found evidence that intestinal cGAS signalling is heightened in obesity. Their analysis indicated activation of the pathway in intestinal samples from humans with obesity and in male mice exposed to a high-calorie diet. Increased signalling was accompanied by greater expression of type I interferons and signs of heightened immune activity among intestinal cells. Type I interferons are powerful antiviral cytokines that change gene expression across many cell types, preparing tissues to respond to infection. However, persistent interferon activity can also reshape epithelial biology, alter interactions with resident microbes and affect the production or handling of small molecules generated in the gut. The observations do not suggest that cGAS is the sole cause of obesity, but they identify it as a potentially important biological response to the intestinal stress associated with excess nutrition.

To test whether the pathway was merely correlated with obesity or actively contributed to it, the investigators deleted the cGAS gene in intestinal epithelial cells. These cells form the gut lining and represent a critical interface between food, microbes and the immune system. They absorb nutrients, maintain the intestinal barrier and release signals that influence organs elsewhere in the body. Mice lacking cGAS in this compartment were protected from diet-induced weight gain despite consuming an obesity-promoting diet. The animals also showed increased energy expenditure, meaning they used more energy over time rather than simply absorbing fewer calories. Their metabolic profiles improved as well, indicating benefits that extended beyond body weight. Because cGAS was removed selectively from the intestinal epithelium, the results highlight the gut lining as a signalling hub rather than implying that global inhibition of cGAS would produce the same effects.

The mechanism depended on the gut microbiota, the dense community of microorganisms that transforms dietary compounds and releases metabolites into the intestinal environment and circulation. When the researchers disrupted or altered the microbiota, the protective metabolic effects of intestinal cGAS deletion were diminished. This finding places bacteria between the intestinal immune sensor and the body’s energy-burning machinery. The study identified Lactobacillus murinus as a particularly important member of this microbial network. In the absence of intestinal epithelial cGAS, the abundance or activity of this bacterium was associated with increased production of indole-3-acetic acid, commonly known as IAA. IAA is an indole-derived metabolite generated from tryptophan by microbial metabolism. Although it is chemically related to plant auxins, in mammals it can act as a signalling molecule capable of influencing immune and metabolic pathways.

According to the study, IAA was a key messenger in the gut-to-adipose effect. The metabolite promoted thermogenesis, the process by which specialized fat cells convert stored chemical energy into heat. This function is most strongly associated with brown and beige adipose tissue, where mitochondria contain uncoupling protein 1, or UCP1. UCP1 dissipates the proton gradient normally used to generate ATP, releasing energy as heat instead. Increased thermogenesis raises total energy expenditure and can counter the accumulation of fat during excess caloric intake. The findings suggest that intestinal cGAS–STING–interferon activity suppresses this beneficial microbial output, while removing cGAS allows an L. murinus–IAA axis to become more active and stimulate heat-producing fat. In this model, an immune signal in the intestine changes microbial chemistry, and that chemistry alters the behaviour of adipose tissue.

The study’s implications extend beyond a simple relationship between inflammation and weight gain. The intestine must continuously distinguish harmless dietary and microbial signals from genuine danger, and cGAS is part of the molecular machinery that makes those judgements. Nutrient overload, epithelial stress and changes in microbial communities may increase the amount of DNA or DNA-like material sensed by the pathway, producing interferon responses that are appropriate in some circumstances but metabolically costly when sustained. By reducing the availability of IAA, chronic intestinal cGAS activity could weaken thermogenic capacity and favour energy storage. This proposed circuit offers a possible explanation for how local immune activation contributes to systemic metabolic disease without requiring inflammation to begin in adipose tissue itself.

The researchers caution, however, that the findings currently provide a stronger mechanistic case in male mice than in humans. The human observations show that intestinal cGAS signalling is activated in people with obesity, but they do not establish that blocking the pathway would cause weight loss or improve metabolic disease in patients. Sex, age, diet, genetics and the composition of the microbiota could all affect the pathway, and the study’s central animal experiments were conducted in males. IAA is also not a universal therapeutic answer: its effects may depend on dose, tissue exposure, receptor signalling and the wider microbial community in which it is produced. Manipulating L. murinus or administering IAA would require careful testing for safety, durability and unintended effects on immunity.

Even with those limitations, the work identifies a striking therapeutic concept: treating obesity by rewiring an immune–microbial–metabolic circuit in the intestine. Future strategies could seek to inhibit cGAS or STING selectively in intestinal epithelial cells, temper excessive type I interferon signalling, support beneficial microbial producers of IAA or deliver metabolites that enhance adipose thermogenesis. Such approaches would need to preserve the essential infection-fighting functions of cGAS while avoiding systemic immune suppression. The study by Deng, Meng, Yang and colleagues therefore adds the intestinal lining to the growing list of tissues that can control whole-body energy balance. It also reinforces a broader lesson of modern metabolic biology: the route to healthier fat may begin not in fat itself, but in the molecular dialogue between gut cells and the microbes living alongside them.

Subject of Research: Intestinal cGAS–STING–type I interferon signalling, gut microbiota, indole-3-acetic acid and obesity-related energy metabolism.

Article Title: Intestinal cGAS–STING–IFN signalling promotes obesity by downregulating microbiota-derived IAA in male mice.

Article References: Deng, J., Meng, W., Yang, Y. et al. “Intestinal cGAS–STING–IFN signalling promotes obesity by downregulating microbiota-derived IAA in male mice.” Nature Metabolism 8, 1713–1729 (2026). https://doi.org/10.1038/s42255-026-01562-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42255-026-01562-4

Keywords: cGAS, STING, type I interferon, intestinal epithelium, obesity, gut microbiota, Lactobacillus murinus, indole-3-acetic acid, IAA, adipose thermogenesis, energy expenditure.

Recent research has brought transformative clarity to the landscape of small intestinal function by mapping the spatial organization of nutrient absorption and epithelial defense mechanisms within this vital organ. This emerging body of knowledge reveals that the small intestine is intricately zonated, both longitudinally and along the apical-basal axis of its epithelial cells. Far from being a simple conduit, this segment of the gut exhibits highly specialized regions, each uniquely equipped with gene expression profiles, signaling pathways, and epigenetic marks that define their role in digestion and protection.

Such zonation is not merely a developmental artifact but a robust, actively maintained feature that persists throughout adulthood. The establishment of regionally distinct gene expression patterns is orchestrated during development by a complex interplay of developmental signals, transcription factors, and epigenetic modifications. These molecular determinants ensure that the proximal, mid, and distal portions of the small intestine execute specialized tasks optimized for processing diverse nutrients, from sugars and amino acids to lipids and micronutrients.

Simultaneously, apical-basal compartmentalization within individual epithelial cells further fine-tunes absorptive processes and barrier functions. This polarized organization supports an elegant division of labor between nutrient uptake at the villus tip and immune surveillance and regeneration at the crypt base. The spatial arrangement ensures efficient absorption while preserving the integrity of the epithelial barrier, protecting against pathogens and toxins, a balance that is critical for maintaining gut homeostasis.

Technological advances such as spatial transcriptomics and single-cell sequencing have been pivotal in dissecting the molecular blueprint of small intestinal epithelium. These techniques allow scientists to deconvolute complex gene expression patterns with high spatial precision, revealing that even adjacent zones along the intestine display distinct cellular populations and unique molecular signatures. This precision has provided unprecedented insights into how the gut adapts and maintains its functional compartments.

On the functional front, this regional organization translates into distinct modes of nutrient absorption. For example, the duodenum specializes in the absorption of iron and calcium, while the jejunum is geared toward absorbing carbohydrates and amino acids efficiently. The ileum, in turn, specializes in bile acid and vitamin B12 uptake. These functional divisions correspond tightly with differential gene expression and transporter localization, depicting a tightly integrated system optimized for maximal nutrient retrieval.

Importantly, the functional compartmentalization extends beyond nutrient absorption to encompass protection and immune responses. The small intestine must mount rapid and localized responses to microbial invasion and dietary antigens without compromising its absorptive efficiency. The spatially defined zones facilitate the coexistence of these seemingly opposing functions, mediated by locally tuned immune cells and epithelial interactions shaped by molecular cues.

Understanding this natural zonation is not just of academic interest but has profound implications for gastrointestinal diseases. Many disorders preferentially affect certain regions of the small intestine, illuminating the fact that the local tissue environment profoundly impacts disease pathogenesis. Conditions such as celiac disease typically target the proximal small intestine, while Crohn’s disease often involves the terminal ileum. Deciphering the molecular architecture of these zones may unlock novel therapeutic targets tailored to the regional vulnerabilities of the gut.

The maintenance of zonated gene expression into adulthood highlights the dynamic nature of the intestinal epithelium, which constantly renews itself yet preserves regional identity. Epigenetic mechanisms, including DNA methylation and histone modifications, appear to act as molecular “memory” systems, ensuring that newly generated epithelial cells inherit the correct gene expression patterns specific to their region. This stability is crucial, as disruptions in zonation could lead to malabsorption or increased susceptibility to disease.

Developmentally, gradients of morphogens such as Wnt, BMP, and Hedgehog pathways establish the initial blueprint of small intestinal zonation. These signals regulate transcription factors that specify epithelial cell type and function along the intestine’s length. Subsequent refinement by environmental factors, including diet and the microbiota, further modulates these regional identities, demonstrating a fascinating intersection of genetics and external influences in shaping gut function.

Furthermore, the epithelial cells’ polarity, from apical microvilli involved in nutrient uptake to basal domains interfacing with underlying tissues, is critical in segregating metabolic and defensive functions. This axis is reinforced by cell junctions and trafficking machinery that regulate protein and lipid distribution, enabling different functional compartments within the same cell to operate with remarkable autonomy.

The increasing resolution of mapping techniques also reveals that small intestinal zonation is mirrored at the level of the stromal and immune microenvironment, which interact with the epithelium to potentiate regional specialization. The cross-talk between immune cells, fibroblasts, and epithelial compartments creates micro-niches finely tuned to support unique metabolic and immunological functions, emphasizing the organ’s complexity.

This paradigmatic shift in our understanding of small intestinal biology underscores how regional specialization underpins critical physiological processes. It opens up exciting avenues for precision medicine approaches targeting specific intestinal segments or cell types, potentially altering the treatment landscape for a host of gastrointestinal diseases by harnessing the organ’s inherent zonal biology.

With the field advancing rapidly, future research will likely focus on how external insults like diet, microbiota shifts, and chronic inflammation disrupt small intestinal zonation and how these disruptions contribute to diseases such as inflammatory bowel disease and malabsorptive syndromes. Understanding the resilience and plasticity of zonation could inform new interventions aimed at restoring healthy intestinal function.

In summary, the small intestine’s regional organization is a testament to biological specialization, illustrating how spatially confined gene expression and cellular functions collaborate to balance the dual imperatives of nutrient absorption and barrier defense. The refined molecular and cellular map of this organ reshapes our conception of gut physiology and disease, highlighting the importance of viewing the small intestine not as a simple vessel but as a highly orchestrated, compartmentalized landscape.

As this groundbreaking research unfurls, it challenges existing paradigms and sets the stage for innovative therapeutic strategies. By embracing the small intestine’s natural zonation, clinicians and researchers can better understand the nuances of digestive health and pathology, ultimately improving outcomes in diseases that have long challenged medicine. This insight into the architectural and functional compartmentalization of the gut is poised to transform our relationship with one of our body’s most crucial yet complex organs.

Subject of Research:
Spatial and molecular regional organization of nutrient absorption across the small intestine, including epigenetic, transcriptional, and functional zonation in epithelial cells and its implications for gastrointestinal physiology and diseases.

Article Title:
Regional organization of nutrient absorption across the small intestine

Article References:
Zwick, R.K., Sharpley, M., Rispal, J. et al. Regional organization of nutrient absorption across the small intestine. Nat Rev Gastroenterol Hepatol (2026). https://doi.org/10.1038/s41575-026-01225-5

Image Credits: AI Generated